News | August 03, 2025
Beta-HPV can directly cause skin cancer in immunocompromised people
cSCC is one of the most common cancers in the U.S. and globally
cSCC is one of the most common cancers in the U.S. and globally
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
A triple-action Formula for comprehensive respiratory relief
EBITDA before special items decreases to €4.08 billion (7.4%)
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Subscribe To Our Newsletter & Stay Updated
